Recent studies have highlighted that inflammatory biomarkers, such as interleukin-6 (IL-6) and (hsCRP), are associated with an increased risk of recurrent cardiovascular events following ischemic stroke or transient ischemic attack. This evidence concerns the gene IL6 and ischemic stroke.